These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 35334224)
1. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland. Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H Lancet Psychiatry; 2022 May; 9(5):353-362. PubMed ID: 35334224 [TBL] [Abstract][Full Text] [Related]
2. Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case-control study in Finland. Rubio JM; Kane JM; Tanskanen A; Tiihonen J; Taipale H Lancet Psychiatry; 2024 Jun; 11(6):443-450. PubMed ID: 38697177 [TBL] [Abstract][Full Text] [Related]
3. Association Between Clozapine Exposure and Risk of Hematologic Malignancies in Veterans With Schizophrenia. Brainerd DR; Alexander B; Tague MJ; Lund BC J Clin Psychiatry; 2024 May; 85(2):. PubMed ID: 38767931 [No Abstract] [Full Text] [Related]
4. Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland. Taipale H; Solmi M; Lähteenvuo M; Tanskanen A; Correll CU; Tiihonen J Lancet Psychiatry; 2021 Oct; 8(10):883-891. PubMed ID: 34474013 [TBL] [Abstract][Full Text] [Related]
5. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Tiihonen J; Lönnqvist J; Wahlbeck K; Klaukka T; Niskanen L; Tanskanen A; Haukka J Lancet; 2009 Aug; 374(9690):620-7. PubMed ID: 19595447 [TBL] [Abstract][Full Text] [Related]
6. Pneumonia Risk, Antipsychotic Dosing, and Anticholinergic Burden in Schizophrenia. Luykx JJ; Correll CU; Manu P; Tanskanen A; Hasan A; Tiihonen J; Taipale H JAMA Psychiatry; 2024 Oct; 81(10):967-975. PubMed ID: 38922592 [TBL] [Abstract][Full Text] [Related]
7. Haematologic malignancies associated with clozapine Chrétien B; Lelong-Boulouard V; Chantepie S; Sassier M; Bertho M; Brazo P; Humbert X; Alexandre J; Fedrizzi S; Dolladille C Psychol Med; 2021 Jul; 51(9):1459-1466. PubMed ID: 32036793 [TBL] [Abstract][Full Text] [Related]
8. Antipsychotic Use and Risk of Low-Energy Fractures in People With Schizophrenia: A Nationwide Nested Case-Control Study in Finland. Solmi M; Lähteenvuo M; Correll CU; Tanskanen A; Tiihonen J; Taipale H Schizophr Bull; 2023 Jan; 49(1):78-89. PubMed ID: 36334051 [TBL] [Abstract][Full Text] [Related]
9. Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland. Ingimarsson O; MacCabe JH; Haraldsson M; Jónsdóttir H; Sigurdsson E BMC Psychiatry; 2016 Dec; 16(1):441. PubMed ID: 27955666 [TBL] [Abstract][Full Text] [Related]
10. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis. Hägg S; Rosenius S; Spigset O Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898 [TBL] [Abstract][Full Text] [Related]
11. Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims. Lambert BL; Chou CH; Chang KY; Tafesse E; Carson W Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):417-25. PubMed ID: 15786516 [TBL] [Abstract][Full Text] [Related]
12. Clozapine-induced agranulocytosis in Finland, 1982-2007: long-term monitoring of patients is still warranted. Lahdelma L; Appelberg B J Clin Psychiatry; 2012 Jun; 73(6):837-42. PubMed ID: 22480452 [TBL] [Abstract][Full Text] [Related]
13. Comparative Effectiveness of Antipsychotic Drugs for Rehospitalization in Schizophrenia-A Nationwide Study With 20-Year Follow-up. Taipale H; Mehtälä J; Tanskanen A; Tiihonen J Schizophr Bull; 2018 Oct; 44(6):1381-1387. PubMed ID: 29272458 [TBL] [Abstract][Full Text] [Related]
14. Antipsychotic drugs and risk of newly diagnosed tuberculosis in schizophrenia. Liu HC; Hung GC; Yang SY; Liao YT; Pan CH; Chen CC; Kuo CJ Psychiatry Clin Neurosci; 2018 Oct; 72(10):789-800. PubMed ID: 29987915 [TBL] [Abstract][Full Text] [Related]
15. Does switching to another antipsychotic in patients with clozapine-associated granulocytopenia solve the problem? Case series of 18 patients. Coşar B; Taner ME; Eser HY; Altınöz AE; Tarhan R J Clin Psychopharmacol; 2011 Apr; 31(2):169-73. PubMed ID: 21346615 [TBL] [Abstract][Full Text] [Related]
16. Real-world effectiveness of antipsychotic doses for relapse prevention in patients with first-episode schizophrenia in Finland: a nationwide, register-based cohort study. Taipale H; Tanskanen A; Correll CU; Tiihonen J Lancet Psychiatry; 2022 Apr; 9(4):271-279. PubMed ID: 35182475 [TBL] [Abstract][Full Text] [Related]
17. Antipsychotic reexposure and recurrent pneumonia in schizophrenia: a nested case-control study. Hung GC; Liu HC; Yang SY; Pan CH; Liao YT; Chen CC; Kuo CJ J Clin Psychiatry; 2016 Jan; 77(1):60-6. PubMed ID: 26613551 [TBL] [Abstract][Full Text] [Related]
18. Risk Factors, Incidence, and Outcomes of Neuroleptic Malignant Syndrome on Long-Acting Injectable vs Oral Antipsychotics in a Nationwide Schizophrenia Cohort. Guinart D; Taipale H; Rubio JM; Tanskanen A; Correll CU; Tiihonen J; Kane JM Schizophr Bull; 2021 Oct; 47(6):1621-1630. PubMed ID: 34013325 [TBL] [Abstract][Full Text] [Related]
19. [Clozapine and agranulocitosis in Spain: do we have a safer population? A 5-year hematologic follow-up]. Pons A; Undurraga J; Batalla A; Bernardo M Rev Psiquiatr Salud Ment; 2012; 5(1):37-42. PubMed ID: 22854502 [TBL] [Abstract][Full Text] [Related]
20. Antipsychotic exposure and infection risk in people with schizophrenia spectrum disorders during the COVID-19 pandemic: a Danish nationwide registry study. Nersesjan V; Christensen RHB; Andersen EW; Kondziella D; Benros ME Lancet Psychiatry; 2024 Oct; 11(10):796-806. PubMed ID: 39241794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]